Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

mitoxantrone hydrochloride

(MY-toh-ZAN-trone HY-droh-KLOR-ide)
A drug used with other drugs to treat acute myeloid leukemia in adults, advanced prostate cancer that did not get better with hormone therapy, and certain forms of multiple sclerosis. It is also being studied in the treatment of other types of cancer. Mitoxantrone hydrochloride damages the cell’s DNA and may kill cancer cells. It also blocks a certain enzyme needed for cell division and DNA repair. Mitoxantrone hydrochloride may also stop certain immune cells from causing damage to the brain and spinal cord. It is a type of antineoplastic antibiotic and a type of topoisomerase inhibitor.
More Information
Search NCI's Dictionary of Cancer Terms